Obesity Differs from Diabetes Mellitus in Antibody and T Cell Responses Post COVID-19 Recovery.
Journal article
Ali M. et al, (2024), Clinical and experimental immunology
Gonadal androgens are associated with decreased type I interferon production by plasmacytoid dendritic cells and increased IgG titres to BNT162b2 following co-vaccination with live attenuated influenza vaccine in adolescents.
Journal article
Sampson OL. et al, (2024), Frontiers in immunology, 15
Prevalence of resistance-associated viral variants to the HIV-specific broadly neutralising antibody 10-1074 in a UK bNAb-naïve population.
Journal article
Zacharopoulou P. et al, (2024), Frontiers in immunology, 15
Rapid antiretroviral therapy in primary HIV-1 infection enhances immune recovery.
Journal article
Thornhill JP. et al, (2023), AIDS (London, England)
Therapeutic vaccination following early antiretroviral therapy elicits highly functional T cell responses against conserved HIV-1 regions.
Journal article
Kopycinski J. et al, (2023), Sci Rep, 13
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
Journal article
Barnes E. et al, (2023), Nature Medicine, 29, 1760 - 1774
The impact of pre-existing cross-reactive immunity on SARS-CoV-2 infection and vaccine responses
Journal article
Murray SM. et al, (2023), Nature Reviews Immunology, 23, 304 - 316
Rapid escape of new SARS-CoV-2 Omicron variants from BA.2-directed antibody responses
Journal article
Dijokaite-Guraliuc A. et al, (2023), Cell Reports, 42, 112271 - 112271
Booster Vaccination Against SARS-CoV-2 Induces Potent Immune Responses in People With Human Immunodeficiency Virus
Journal article
Fidler S. et al, (2023), Clinical Infectious Diseases, 76, 201 - 209
Paediatric HIV slow-progression is associated with early CD8+ T-cell PD-1 expression and a stem-like phenotype.
Journal article
Adriano Vieira V. et al, (2023), JCI insight
A calculated risk: Evaluating HIV resistance to the broadly neutralising antibodies10-1074 and 3BNC117
Journal article
Zacharopoulou P. et al, (2022), Current Opinion in HIV and AIDS, 17, 352 - 358
Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Journal article
Tuekprakhon A. et al, (2022), Cell, 185, 2422 - 2433.e13
A simple, robust flow cytometry-based whole blood assay for investigating sex differential interferon alpha production by plasmacytoid dendritic cells
Journal article
Sampson O. et al, (2022), Journal of Immunological Methods, 504, 113263 - 113263
An exploration of how broadly neutralizing antibodies might induce HIV remission: the 'vaccinal' effect.
Journal article
Tipoe T. et al, (2022), Current opinion in HIV and AIDS, 17, 162 - 170
Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV
Journal article
Ogbe A. et al, (2022), JCI Insight, 7
The RIO trial: rationale, design, and the role of community involvement in a randomised placebo-controlled trial of antiretroviral therapy plus dual long-acting HIV-specific broadly neutralising antibodies (bNAbs) in participants diagnosed with recent HIV infection-study protocol for a two-stage randomised phase II trial.
Journal article
Lee MJ. et al, (2022), Trials, 23
BreakAlign: a Perl program to align chimaeric (split) genomic NGS reads and allow visual confirmation of novel retroviral integrations.
Journal article
Marchi E. et al, (2022), BMC bioinformatics, 23
Divergent trajectories of antiviral memory after SARS-CoV-2 infection
Journal article
Tomic A. et al, (2022), Nature Communications, 13
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Journal article
Ahern DJ. et al, (2022), Cell, 185, 916 - 938.e58
Immunotherapeutic approaches to HIV cure and remission
Journal article
Lee MJ. et al, (2022), Current Opinion in Infectious Diseases, 35, 31 - 41